Harry Rubash

Agilent Technologies has named Allison Ballmer as senior vice president of strategy and corporate development, reporting to President and CEO Mike McMullen.

Ballmer joined Agilent in May 2018 as vice president of business development and strategy for the company's Diagnostics and Genomics business. Prior to that, she worked for more than a decade at Roche. She is currently lead director of the board of directors at Mission Bio.

Swiss life sciences company Lunaphore Technologies appointed Paolo Ascierto and Jérôme Galon, who are experts in immuno-oncology, to its new Scientific Advisory Board.

Ascierto is the director of the Department of Melanoma, Cancer Immunotherapy, and Development Therapeutics at the National Tumor Institute in Naples, Italy. He is a member of the Steering Committee of the Society of Melanoma Research and the board of directors of the Society of Immunotherapy of Cancer. He is also president of the Fondazione Melanoma Onlus and the Campania Society of ImmunoTherapy of Cancer.

Galon is the director of research at INSERM (the French National Institute of Health and Medical Research) and head of the Laboratory of Integrative Cancer Immunology at the Cordeliers Research Center in Paris. He is the cofounder of HalioDx and chairman of its scientific council.

MeMed has appointed Troy Boutelle as VP of commercial, North America and GM, US. He will lead Haifa, Israel-based MeMed's operation in North America from Boston. He has 20 years of leadership experience at life science companies including at Eurofins-Viracor where he was its VP of sales of marketing prior to joining MeMed. He previously was commercial lead at Thermo Fisher Scientific where he led the commercial team for the Americas microbiology team.

DermTech has appointed Ray Akhavan as its general counsel. Most recently, Akhavan served as associate general counsel and chief intellectual property counsel at Ancestry. Prior to Ancestry, Akhavan served as general counsel and chief intellectual property counsel at Caris Life Sciences. He has also worked as a research biologist at the National Institutes of Health and as a patent examiner at the US Patent and Trademark Office. 

Ryan Siurek has joined Biodesix as chief accounting officer. He was previously SVP, chief accounting officer and controller of Vail Resorts. Prior to that, he held various accounting and finance roles at Sprint, including VP controller and chief accounting officer, and VP, divisional CFO for the prepaid and wholesale and enterprise solutions divisions.

SomaLogic this week announced several new executive appointments.

Jason Cleveland will be the company's new chief technology officer. He joined SomaLogic in 2015 as a consultant and became a principal research fellow in 2018. Prior to SomaLogic, he was cofounder, chairman, and CEO of Asylum Research, a manufacturer of atomic force microscopes (AFM). He began his career at Digital Instruments, an early AFM maker. Cleveland has a PHD in physics from the Universiy of California, Santa Barbara and is a fellow of the American Physical Society.

SomaLogic has also appointed Angela Bakker Lee as its executive VP for healthcare markets, Tracy Hervey as executive VP for life science markets, and David McGovern as senior VP of marketing.

Prior to SomaLogic, Bakker Lee most recently served as chief strategy officer at Quid, an AI text analytics platform provider. Bakker Lee also previously led IBM's Global Business Services Healthcare for North America. Prior to IBM, Bakker Lee spent 15 years with ZS Associates, a management consulting firm specializing in commercial strategy and sales and marketing operations. Before ZS Associates, she worked at Molecular Applications Group.

Hervey most recently served as chief commercial officer at Amplity Health. Prior to Amplity Health, she served as VP of global accounts at Icon. Before Icon, Hervey held sales leadership roles at data science firm Iqvia and PPD, a global contract research organization.

McGovern previously served as strategic payer marketing lead at Pfizer. Prior to Pfizer, McGovern served as VP of marketing and business development at Change Healthcare. Before Change Healthcare, he held various leadership roles in global commercial development, marketing, and market access at Johnson & Johnson, Merck, and Otsuka. McGovern has also served as VP of marketing at Nupathe, which was later sold to Teva Pharmaceuticals.

Diaceutics, a data analytics and services provider for precision medicine, has appointed Deborah Davis as non-executive chair effective Jan. 4, 2021. Davis spent 25 years in CEO and executive roles including 14 years in European and global senior leadership roles at internet platform businesses PayPal and eBay; and technology companies Symantec and Verizon. She currently holds a number of non-executive director and board committee positions including with International Personal Finance, IDEX Biometrics, the Institute of Directors UK, and Which? Ltd.